Christopher J. Bowden

Chief Medical Officer at Agios Pharmaceuticals, Inc.

Christopher J. Bowden

Christopher J. Bowden

Chief Medical Officer at Agios Pharmaceuticals, Inc.

Overview
Career Highlights

Bristol-Myers Squibb Company

RelSci Relationships

3488

Number of Boards

3

Birthday

1962

Age

58

Contact Data
Trying to get in touch with Christopher J. Bowden? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Christopher J. Bowden likely has professional access to. A relationship does not necessarily indicate a personal connection.

President & Chief Executive Officer at Miragen Therapeutics, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Navitor Pharmaceuticals, Inc.

Relationship likelihood: Strong

General Partner at GV Management Co. LLC

Relationship likelihood: Strong

Chief Executive Officer at Zafgen, Inc.

Relationship likelihood: Strong

Co-Founder at Rodin Therapeutics, Inc.

Relationship likelihood: Strong

Founder at Agios Pharmaceuticals, Inc.

Relationship likelihood: Strong

Founder at Agios Pharmaceuticals, Inc.

Relationship likelihood: Strong

Founder at Agios Pharmaceuticals, Inc.

Relationship likelihood: Strong

Founder at Agios Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Executive Officer & Director at Agios Pharmaceuticals, Inc.

Relationship likelihood: Strong

Paths to Christopher J. Bowden
Potential Connections via
Relationship Science
You
Christopher J. Bowden
Chief Medical Officer at Agios Pharmaceuticals, Inc.
Career History
Vice President
2006 - 2014

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer, Kenneth B. Lee and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Chief Medical Officer
2014 - Current

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Executive Director-Europe, Middle East & Africa
2003 - 2006

Bristol-Myers Squibb Company Our company has a strong legacy of innovation that began in New York in 1858 when Edward R. Squibb, M.D., founded a pharmaceutical company in Brooklyn, and in 1887 when two friends, William McLaren Bristol and John Ripley Myers purchased a struggling drug manufacturing firm in Clinton. Together, they laid the foundation for our company today — a global BioPharma leader that continues this legacy of innovation.

Boards & Committees
Member, Board of Directors
2019 - Current
Member, Board of Directors
2017 - Current
Independent Director
Prior
Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Christopher J. Bowden. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Christopher J. Bowden's profile does not indicate a business or promotional relationship of any kind between RelSci and Christopher J. Bowden.